| Literature DB >> 28867986 |
Barbara Thiem1, Małgorzata Kikowska1, Michał P Maliński1, Dariusz Kruszka1, Marta Napierała2, Ewa Florek2.
Abstract
Ecdysteroids are secondary metabolites, widely distributed in the animal and plant kingdoms. They have a wide range of pharmacological effects in vertebrates, including mammals, most of which are beneficial for humans. Therefore, they have become compounds of interest for the pharmaceutical industry due to their adaptogenic, anabolic, hypoglycaemic, hypocholesterolaemic and antimicrobial activities, which are still being researched. Nowadays, ecdysteroids are present as active ingredients in bodybuilding supplements. Because of their complex structures, their chemical synthesis seems unprofitable and impractical. Due to high content of ecdysteroids in many plants, they are primarily obtained by extraction of the plant material. Plant in vitro cultures provide an alternative source of these compounds, helping to avoid problems associated with field production-such as variable yield or dependence on environmental factors, as well as limited availability of natural resources. Plant cell and tissue cultures may be suggested as alternatives for the production of plant biomass rich in pharmaceutically active ecdysteroids. Moreover, the use of common biotechnological strategies, such as elicitation or precursor feeding, may further increase the yield and improve production of these compounds. In this paper, we describe general information about ecdysteroids: their structure, biosynthesis, distribution, role in plants, and we review recent studies on micropropagation of ecdysteroid-producing plants and cell cultures, and potential ability of ecdysteroids enhancement in in vitro cultures.Entities:
Keywords: Ecdysteroids; Elicitation; In vitro cultures; Plant biotechnology; Precursor feeding
Year: 2016 PMID: 28867986 PMCID: PMC5559567 DOI: 10.1007/s11101-016-9483-z
Source DB: PubMed Journal: Phytochem Rev ISSN: 1568-7767 Impact factor: 5.374
Fig. 1Structures of the most common ecdysteroids A 20-hydroxyecdysone (R=H) and polypodine B (R=OH) B rubrosterone, an ecdysteroid without aliphatic side chain
Fig. 2The synthesis of 20-hydroxyecdysone
Examples of ecdysteroid-producing in vitro systems
| Plant species/family | Type of in vitro culture | Best medium and/or treatment for highest metabolites production | Secondary metabolites | Authors |
|---|---|---|---|---|
|
| Cell suspension | MS with NAA (1.5 μM) + BAP (1.5 μM) | 20E | Wang et al. ( |
|
| Hairy roots | Hormone free MS | 20E | Kim et al. ( |
|
| Shoot and root cultures | MS with NAA (0.5 μM) | Ajugalactone, cyasterone, 29-norcyasterone, sengosterone, 29-norsengosterone, 20E | Tomas et al. ( |
| Cell suspension | MS with NAA (1.0 mg l−1) | Filippova et al. ( | ||
| Hairy roots | Hormone free MS | Matsumoto and Tanaka ( | ||
|
| Cell suspension | B5 with 2,4-D (2.3 μM) | Cyasterone, 20E, turkesteron | Cheng et al. ( |
| Hairy roots | MS with BAP (2.2 μM) + IBA (2.5 μM) | |||
|
| Cell suspension | MS with 2,4-D (0.165 mg l−1) + Kin (0.107 mg l−1) | 20E, polypodine B | Corio-Costet et al. ( |
|
| Cell suspension | MS with BAP (3.0 mg l−1) + NAA (0.2 mg l−1) | 20E | Wang et al. ( |
|
| Prothalli cultures | ½ MS | Ecdysone, 20E, polypodine B, pterosterone | Reixach et al. ( |
| ½ MS | Reixach et al. ( | |||
| ½ MS with BAP (to 30 mg l−1) + 2,4-D (0–3.0 mg l−1) | Camps et al. ( | |||
|
| Callus and cell suspension | MS with 2,4-D (1.0 μM) + Kin (1.0 μM) | 20E, ecdysone, ponasterone, polypodine B | Macek and Vanek ( |
|
| Hairy roots | Hormone free SH, WPM and B5 | 20E | Skała et al. ( |
|
| Callus and cell suspension | MS with 2,4-D (5.0 mg l−1) | 20E, 20E − 3-acetate, polypodine B | Corio-Costet et al. (1993, |
| Hairy roots | Hormone free MS | Delbecque et al. ( | ||
| Hormone free MS | Corio-Costet et al. ( | |||
|
| Callus | MS with 2,4-D (2.0 ppm) | Ecdysterone | Ravishankar and Mehta ( |
|
| Cell suspensions | B5 with BAP (2.0 mg l−1) + 2,4-D (1.0 mg l−1) | 20E | Sinlaparaya et al. ( |
| B5 with 2,4-D (1.0 mg l−1) + BAP (2.0 mg l−1) | Sinlaparaya et al. ( | |||
| B5 with 2,4-D (1.0 mg l−1) + BAP (2.0 mg l−1) | Thanonkeo et al. ( | |||
| ½ MS with 2,4-D (1.0 mg l−1) + BAP (2.0 mg l−1) | Chamnipa et al. ( |
2,4-D 2,4-dichlorophenoxyacetic acid; 20E 20-hydroxyecdysone B Gamborg’s medium; BAP 6-benzyloaminopurine; IAA indole-3-acetic acid, IBA indole-3-butyric acid; Kin kinetin; MeJA methyl jasmonate; MS Murashige and Skoog medium; MVA mevalonic acid; MVL mevalonic lacton; NAA α-naphthalene acetic acid; SH Schenk and Hildebrandt medium; WPM McCown woody plant medium
Micropropagation of selected ecdosteroid-producing plants
| Plant species/Family | Initial | Shoot regeneration | Root induction | Plantlets acclimatization | Authors |
|---|---|---|---|---|---|
|
| Nodal segments | MS + BAP 5.0 mg l−1 (11 shoots) | ½ MS + IBA 1.0 mg l−1 | 68% | Gnanaraj et al. ( |
|
| Nodal segments | MS + BAP 2.0 mg l−1 + IAA 1.0 mg l−1 | ½ MS + IBA 1.0 mg l−1 (3.4 root/explant) | 80% | Parveen et al. ( |
|
| Callus | MS + BAP 2.0 mg l−1 + NAA 0.5 mg l−1 | MS + IBA 3.0 mg l−1 | 66.67% | Sen et al. ( |
|
| Nodal segments | MS + BAP 5.0 mg l−1 (10 shoots) | ½ MS + IBA 1.0 mg l−1 | 68% | Gnanaraj et al. ( |
|
| Callus | MS + 2,4-D 0.5 mg l−1+, NAA 1.0 mg l−1 + IBA 0.1 mg l−1 + ZT 0.1 mg l−1 | MS + 2,4-D + NAA/IBA + ZT | NA | Duan et al. ( |
|
| Callus | MS + 5.0 BAP mg l−1 + IAA 2.0 mg l−1 (41.5 shoots/callus) | MS + IBA 0.5 mg l−1 (20 roots/shoot) | 82% | Kaul et al. ( |
|
| Shoot tips of axenic seedlings | MS + BAP + IAA/NAA (13 shoots) | MS + NAA (100%) | 80–100% | Thiem et al. ( |
|
| Nodal segments | MS + BAP 2.22 µM + NAA 2.68 µM + 0.1 µM glucose | NA | NA | Vasconcelos et al. ( |
|
| Nodal segments | MS (1.4–1.7 shoots) | MS (100%) | 100% | Flores et al. ( |
|
| Nodal segments | MS + TDZ 1.0 µM (10.3 shoots) | MS (100%) | 80–100% | Flores et al. ( |
|
| Callus | MS + 2,4-D 0.25 mg l−1 + BAP 1.5 mg l−1
| MS + BAP 0.5 mg l−1 + IAA 1.0 mg l−1 (100% root/callus) | NA | Zand et al. ( |
|
| Nodal segments | MS + BAP 1.0 mg l−1
| MS + IAA 1.0 mg l−1 IBA 1.0 mg l−1 | 93% | Sahoo and Chand ( |
|
| Nodal explants | BAP 17.8 µM + NAA 2.15 µM + 5% sucrose (20.88 shoots) | IBA 9.4 µM (95.56%) | Chandramu et al. ( | |
|
| Callus | MS + 2.7 µM TDZ | MS + 1.71 µM IAA + 1.62 µM NAA | 70.33–88.71% | Rani and Nair ( |
|
| Nodal segments with axillary buds | MS + BAP 1.0 µM + NAA 0.5 µM | Treatment with IBA 500 µM/10 min | 95% | Ahmad and Anis ( |
|
| Nodal explants | MS + BAP 5.0 µM + 0.5 µM (16 shoots) | MS + IBA 10 µM | 97% | Ahmad and Anis ( |
|
| Nodal segments | MS + BAP 5.0 µM + NAA 0.5 µM (6.2 shoots) | Treatment with IBA 500 µM/20 min | 95% | Ahmad et al. ( |
2,4-D 2,4-dichlorophenoxyacetic acid; BAP 6-benzylaminopurine; GA gibberrelic acid; IAA indole-3-acetic acid; IBA indole-3-butyric acid; MS Murashige and Skoog medium; NA not available; NAA α-naphthalene acetic acid; TDZ thidiazuron; ZT zeatin